Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms

Aim. To evaluate treatment adherence and prevalence of CYP2C9 and VKORC1 gene mutations in patients with atrial fibrillation (AF) and provide rationale of choice for oral anticoagulation therapy.Material and methods. Treatment adherence was evaluated in 137 AF patients (aged 35-85 years) with quanti...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
Format: Article
Language:English
Published: Столичная издательская компания 2016-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1325
Tags: Add Tag
No Tags, Be the first to tag this record!